105 related articles for article (PubMed ID: 9737663)
1. Origin and properties of soluble CD21 (CR2) in human blood.
Ling NR; Hardie DL; Johnson GD; MacLennan IC
Clin Exp Immunol; 1998 Sep; 113(3):360-6. PubMed ID: 9737663
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
[TBL] [Abstract][Full Text] [Related]
3. Follicular dendritic cells specifically express the long CR2/CD21 isoform.
Liu YJ; Xu J; de Bouteiller O; Parham CL; Grouard G; Djossou O; de Saint-Vis B; Lebecque S; Banchereau J; Moore KW
J Exp Med; 1997 Jan; 185(1):165-70. PubMed ID: 8996252
[TBL] [Abstract][Full Text] [Related]
4. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
Masilamani M; von Kempis J; Illges H
Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
Masilamani M; Apell HJ; Illges H
J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
[TBL] [Abstract][Full Text] [Related]
6. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
Masilamani M; Kassahn D; Mikkat S; Glocker MO; Illges H
Eur J Immunol; 2003 Sep; 33(9):2391-7. PubMed ID: 12938215
[TBL] [Abstract][Full Text] [Related]
7. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD21 in sera and synovial fluid of arthritic patients.
Grottenthaler T; von Kempis J; Goldacker S; Illges H
Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
[TBL] [Abstract][Full Text] [Related]
10. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
Singh A; Vastert SJ; Prakken BJ; Illges H
Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies.
Singh A; Blank M; Shoenfeld Y; Illges H
Rheumatol Int; 2008 May; 28(7):661-5. PubMed ID: 18172655
[TBL] [Abstract][Full Text] [Related]
13. Properties of soluble CR2 in human serum.
Ling NR; Brown B
Immunobiology; 1992 Aug; 185(2-4):403-14. PubMed ID: 1280620
[TBL] [Abstract][Full Text] [Related]
14. Detection of sCD21 in Human Blood Using ELISA is Influenced by Ethylenediaminetetraacetic Acid (EDTA) Containing Blood Collection Tubes.
Linke K; Illges H
Clin Lab; 2015; 61(11):1803-8. PubMed ID: 26732009
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
[TBL] [Abstract][Full Text] [Related]
16. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.
Braun M; Melchers I; Peter HH; Illges H
Int Immunol; 1998 Aug; 10(8):1197-202. PubMed ID: 9723706
[TBL] [Abstract][Full Text] [Related]
17. Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.
Hoefer MM; Illges H
Mol Immunol; 2009 Aug; 46(13):2630-9. PubMed ID: 19524299
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.
Frémeaux-Bacchi V; Aubry JP; Bonnefoy JY; Kazatchkine MD; Kolb JP; Fischer EM
Eur J Immunol; 1998 Dec; 28(12):4268-74. PubMed ID: 9862364
[TBL] [Abstract][Full Text] [Related]
19. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
[TBL] [Abstract][Full Text] [Related]
20. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia.
Ling N; Hansel T; Richardson P; Brown B
Clin Exp Immunol; 1991 Apr; 84(1):16-22. PubMed ID: 1849806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
